Cargando…
A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
A workshop sponsored by the National Cancer Institute and the US Food and Drug Administration addressed past lessons learned and ongoing challenges faced in biomarker development and drug and biomarker codevelopment. Participants agreed that critical decision points in the product life cycle depend...
Autores principales: | Taube, Sheila E., Clark, Gary M., Dancey, Janet E., McShane, Lisa M., Sigman, Caroline C., Gutman, Steven I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773185/ https://www.ncbi.nlm.nih.gov/pubmed/19855077 http://dx.doi.org/10.1093/jnci/djp334 |
Ejemplares similares
-
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An
Abridged Explanation and Elaboration
por: Sauerbrei, Willi, et al.
Publicado: (2018) -
Statistical challenges in the development and evaluation of marker-based clinical tests
por: McShane, Lisa M
Publicado: (2012) -
Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
por: Butterfield, Lisa H, et al.
Publicado: (2010) -
Ethical Issues in Measuring Biomarkers in Children’s Environmental Health
por: Sly, Peter D., et al.
Publicado: (2009) -
An Evaluation Framework for a Novel Process to Codevelop Written and Computable Guidelines
por: Tailor, Amrita, et al.
Publicado: (2023)